ANI PHARMACEUTICALS, INC Repayments of Other Long-term Debt
ANI PHARMACEUTICALS, INC (ANIP) reported Repayments of Other Long-term Debt of $8.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for the quarter ending 2026-06-30 was $4.06M, a 100.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for the quarter ending 2026-03-31 was $4.06M, a 100.05% increase year-over-year.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for the quarter ending 2025-12-31 was $10.16M.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for the quarter ending 2025-09-30 was -$4.06M.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for fiscal 2025 was $10.16M, a 187.62% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for fiscal 2024 was $3.53M, a 17.70% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for fiscal 2023 was $3.00M, a 0.00% change from fiscal 2022.
- ANI PHARMACEUTICALS, INC repayments of other long-term debt for fiscal 2022 was $3.00M, a 72.38% decline from fiscal 2021.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month | Repayments of Other Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.13M 10-Q · filed 2026-08-07 | $18.28M derived: sum of 3 quarters · filed 2026-08-07 | $14.22M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $4.06M 10-Q · filed 2026-05-08 | $14.22M derived: sum of 2 quarters · filed 2026-05-08 | $10.16M derived: sum of 3 quarters · filed 2026-05-08 | $12.19M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $10.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.09M derived: sum of 2 quarters · filed 2026-02-27 | $8.13M derived: sum of 3 quarters · filed 2026-08-07 | $10.16M 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.03M derived: sum of 2 quarters · filed 2026-08-07 | $0.00 10-Q · filed 2025-11-07 | -$288.97M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $4.06M 10-Q · filed 2026-08-07 | -$284.91M derived: sum of 3 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-08 | -$286.94M derived: sum of 2 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$288.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.53M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $292.50M 10-Q · filed 2025-11-07 | ||||
| 2023-12-31 | $3.00M 10-K · filed 2026-02-27 | $0.00 10-K · filed 2024-02-29 | |||
| 2022-12-31 | $3.00M 10-K · filed 2025-02-28 | $0.00 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.66M derived: sum of 2 quarters · filed 2024-02-29 | $8.48M derived: sum of 3 quarters · filed 2024-02-29 | $10.86M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $5.66M derived: sum of 2 quarters · filed 2021-11-01 | $8.03M 10-Q · filed 2021-11-01 | $10.41M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $5.21M 10-Q · filed 2021-08-06 | $7.58M derived: sum of 3 quarters · filed 2022-03-15 | $9.96M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-03-31 | $2.38M 10-Q · filed 2021-05-07 | $4.75M derived: sum of 2 quarters · filed 2022-03-15 | $7.13M derived: sum of 3 quarters · filed 2022-03-15 | $9.51M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.75M derived: sum of 2 quarters · filed 2022-03-15 | $7.13M derived: sum of 3 quarters · filed 2022-03-15 | $8.03M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $4.75M derived: sum of 2 quarters · filed 2021-11-01 | $5.66M 10-Q · filed 2021-11-01 | $6.56M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.28M 10-Q · filed 2021-08-06 | $4.18M derived: sum of 3 quarters · filed 2022-03-15 | $5.08M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $902.00K 10-Q · filed 2021-05-07 | $1.80M derived: sum of 2 quarters · filed 2022-03-15 | $2.71M derived: sum of 3 quarters · filed 2022-03-15 | $2.71M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | $902.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.80M derived: sum of 2 quarters · filed 2022-03-15 | $1.80M derived: sum of 3 quarters · filed 2022-03-15 | $2.71M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $903.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $903.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.80M 10-Q · filed 2020-11-05 | $2.74M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $902.00K 10-Q · filed 2020-08-06 | $1.84M derived: sum of 3 quarters · filed 2021-03-11 | $2.78M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | $902.00K 10-Q · filed 2020-05-07 | $1.84M derived: sum of 2 quarters · filed 2021-03-11 | $2.78M derived: sum of 3 quarters · filed 2021-03-11 | $2.78M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | $938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.88M derived: sum of 2 quarters · filed 2021-03-11 | $1.88M derived: sum of 3 quarters · filed 2021-03-11 | $2.81M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $937.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.88M 10-Q · filed 2019-11-06 | $1.88M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $938.00K 10-Q · filed 2019-08-07 | $938.00K derived: sum of 3 quarters · filed 2020-02-27 | $938.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $938.00K 10-Q · filed 2019-05-09 | $938.00K derived: sum of 2 quarters · filed 2020-02-27 | $938.00K derived: sum of 3 quarters · filed 2020-02-27 | $938.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |